Toshiro Konishi
University of Tokyo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Toshiro Konishi.
Annals of Surgery | 1995
Toshiro Konishi; Mamoru Hiraishi; Keiichi Kubota; Yasutsugu Bandai; Masatoshi Makuuchi; Yasuo Idezuki
ObjectiveThe authors used prolamine (Ethibloc, Ethicon GmBH, Norderstedt, Germany) for segmental obstruction of the pancreatic duct to prevent pancreatic fistula development after distal pancreatectomy combined with total gastrectomy for gastric malignancies. Summary Background DataSummary Background Data the initial clinical application of prolamine was pancreatic duct obstruction for patients with pancreatitis and undergoing pancreatic transplantation and pancreaticoduodenectomy for pancreatic cancer, there are no reports on prevention of pancreatic fistula formation after distal pancreatectomy. MethodsProlamine (0.2 mL) was injected into the distal segment of the main duct in the remaining pancreata of 51 patients. Small pancreatic ducts on the cut surface, from which prolamine extravasates, were closed by ligation, the main duct was ligated doubly, and the transected pancreatic margin was closed 15 minutes after phenylpropanolamine hydrochloride injection. ResultsResults patient developed a pancreatic fistula or the complication of arterial bleeding due to prolonged infection. ConclusionConclusion obstruction of the pancreatic duct with prolamine is useful for preventing pancreatic fistula development after distal pancreatectomy.
Japanese Journal of Cancer Research | 2000
Shogo Kikuchi; Toshifusa Nakajima; Osamu Kobayashi; Tatsuo Yamazaki; Masahiro Kikuichi; Kiyoshi Mori; Shinsuke Oura; Hideaki Watanabe; Hirokazu Nagawa; Reiji Otani; Naoyuki Okamoto; Michiko Kurosawa; Haruyuki Anzai; Takuji Kubo; Toshiro Konishi; Shunji Futagawa; Noboru Mizobuchi; Oichiro Kobori; Ruriko Kaise; Tosiya Sato; Yutaka Inaba; Osamu Wada
Helicobacter pylori is thought to be involved in the pathogenesis of gastric cancer, but the time point at which it produces its effects (critical time) is unknown. We measured the serum level of H. pylori antibody in 787 gastric cancer patients and 1007 controls aged 20 to 69. Odds ratios for different gastric cancer types and stages were determined for each 10‐year age class. The overall odds ratio for gastric cancer decreased with age, being 7.0 for those aged 20–29, 14.5 for those aged 30–39, 9.1 for those aged 40–49, 3.5 for those aged 50–59, and 1.5 for those aged 60–69 (trend in odds ratios: P < 0.01). However, there was no such age‐dependent trend for early diffuse‐type cancer; the odds ratios were 12.6, 4.0, 7.2, 6.5, and 18.5 respectively (P=0.29). Early cancer tended to show higher seroprevalence than advanced cancer, especially in older subjects. No significant difference in seroprevalence was observed between diffuse and intestinal cancers within each age‐class. Seroreversion must have occurred in the time interval between the critical time and the diagnosis of the cancer, especially in older patients. The age‐dependent relationship between H. pylori and gastric cancer may be due to seroreversion, which itself may be independent of age. This age‐independence indicates that prolonged exposure to H. pylori does not increase the magnitude of its influence on gastric carcinogenesis. Possible mechanisms through which H. pylori exerts pathogenic effects are continuous inflammation in adulthood and/or irreversible damage to gastric mucosa in childhood or the teenage years.
The American Journal of Gastroenterology | 1999
Hideyuki Hiraishi; Toshiro Konishi; Shin’ichi Ota; Tadahito Shimada; Akira Terano; Tsuneaki Sugimoto
Although mesenteric vasculitis due to systemic lupus erythematosus (SLE) is relatively uncommon, it is the most dangerous manifestation associated with high mortality. We describe the case of a SLE patient with life-threatening gastrointestinal hemorrhage due to mesenteric vasculitis in whom methylprednisolone pulse therapy was quite effective in controlling the hemorrhage and resulted in a satisfactory long term outcome. A 47-yr-old woman presenting with high fever, rash, and melena was diagnosed with SLE from positive antinuclear antibodies, anti-dsDNA, and low complement titers. Although fever and rash subsided with administration of prednisolone, massive hematemesis appeared with melena. Endoscopy demonstrated bleeding ulceration of the antrum, which was intractable despite intensive antiulcer therapy and transfusion. Surgical exploration revealed ileal penetration, and multiple bleeding ulcerations were observed over the resected ileum as well as the antral ulceration. However, bleeding persisted after surgery and surgical findings prompted us to select methylprednisolone pulse. Hemorrhage responded promptly to the therapy, and the patient has remained well since then for >10 yr. Our report indicates that corticosteroid pulse may serve as one of the therapeutic options for SLE with massive hemorrhage due to widespread mesenteric vasculitis.
Japanese Journal of Cancer Research | 2002
Shogo Kikuchi; Toshifusa Nakajima; Osamu Kobayashi; Tatsuo Yamazaki; Masahiro Kikuichi; Kiyoshi Mori; Shinsuke Oura; Hideaki Watanabe; Hirokazu Nagawa; Reiji Otani; Naoyuki Okamoto; Michiko Kurosawa; Haruyuki Anzai; Toshiro Konishi; Shunji Futagawa; Noboru Mizobuchi; Oichiro Kobori; Ruriko Kaise; Yutaka Inaba; Osamu Wada
A case‐control study was conducted to evaluate the relationship between smoking or drinking doses and risk for stomach cancer, and to clarify whether the relationship is dose‐dependent or U‐shaped. Smoking dose was categorized as 0,1–399, 400–799, or 800+ cigarette‐years, and drinking dose as 0, occasional/0.1–134.9, 135–1349.9, or 1350+ alcohol‐years (ml of pure alcohol intake per day multiplied by years of drinking). Helicobacter pylori status was determined by serology for adjustment. Using logistic regression, the adjusted effects of smoking and drinking doses on risk for stomach cancer were calculated for both genders. Among male subjects, the odds ratios (95% confidence intervals (CIs)) were 1.29 (0.76, 2.18) for 1–399, 1.71 (1.05, 2.80) for 400–799 and 2.46 (1.49, 4.07) for 800+ cigarette‐years compared with never‐smokers, and 1.89 (0.97, 3.69) for never‐drinkers, 2.82 (1.63, 4.86) for 135–1349.9 and 2.84 (1.97, 4.83) for 1350.0+, compared with occasional/0.1–134.9 alcohol‐years. Among female subjects, they were 0.44 (0.20, 1.00) for 1–399 and 2.471 (0.91, 6.68) for 400+ cigarette‐years compared with never‐smokers, and 1.54 (0.90, 2.63) for never‐drinkers and 1.39 (0.66, 2.93) for 135.0+ alcohol‐years. Smoking seems to exert a linear effect and drinking, a J‐ or U‐shaped effect on risk for stomach cancer, although there might be a dip of risk in light smokers among female subjects.
Surgical Infections | 2012
Shinya Kusachi; Nobuichi Kashimura; Toshiro Konishi; Junzo Shimizu; Masato Kusunoki; Masaaki Oka; Toshiro Wakatsuki; Junjiro Kobayashi; Yoshiki Sawa; Hiroshi Imoto; Noboru Motomura; Haruo Makuuchi; Kazuo Tanemoto; Yoshinobu Sumiyama
PURPOSE This study evaluated the influence of surgical site infections (SSIs) after abdominal or cardiac surgery on the post-operative duration of hospitalization and cost. METHODS A retrospective 1:1 matched case-control study of length of stay and healthcare expenditures for patients who were discharged from nine hospitals, between April 1, 2006 and March 31, 2008, after undergoing abdominal or cardiac surgery and who did and did not have a SSI. RESULTS Information was obtained from 246 pairs of patients who had undergone abdominal surgery and 27 pairs of patients who had undergone cardiac surgery. Overall, the mean post-operative hospitalization was 20.7 days longer and the mean post-operative healthcare expenditure was
Surgery Today | 1997
Toshiro Konishi; Yasuo Idezuki; Hiroyoshi Kobayashi; Kaoru Shimada; Shigetomi Iwai; Keizo Yamaguchi; Nagao Shinagawa
8,791 higher in the SSI group than for the SSI-free group. Among the patients who had undergone abdominal surgery, development of SSI extended the average hospitalization by 17.6 days and increased the average healthcare expenditure by
FEBS Letters | 2001
Wei Tang; Keita Seino; Mieko Ito; Toshiro Konishi; Hisato Senda; Masatoshi Makuuchi; Naoya Kojima; Tsuguo Mizuochi
6,624. Among the patients who had undergone cardiac surgery, SSI extended the post-operative hospitalization by an average of 48.9 days and increased the post-operative healthcare expenditure by an average of
Infection Control and Hospital Epidemiology | 2002
Keita Morikane; Midori Nishioka; Hisami Tanimura; Hiroe Noguchi; Toshiro Konishi; Hiroyoshi Kobayashi
28,534. CONCLUSIONS Under the current healthcare system in Japan, the development of SSI after abdominal surgery necessitates extension of hospitalization two-fold and increases the post-operative healthcare expenditure 2.5-fold. Development of SSI after cardiac surgery necessitates extension of hospitalization fourfold and increases the healthcare expenditure six-fold.
Dermatology | 2006
Yasushi Harihara; Toshiro Konishi; Hiroyoshi Kobayashi; Kaoru Furushima; Kei Ito; Tamaki Noie; Satoshi Nara; Kumi Tanimura
The postoperative development of methicillincephem-resistantStaphylococcus aureus (MRSA) enteritis can be fatal unless it is detected at an early stage and treated with effective antibacterial agents. We report herein a Japanese multicenter collaborative clinical study on the efficacy and safety of oral vancomycin hydrochloride (VCM) in the treatment of MRSA enteritis. A total of 49 patients who had been diagnosed as having, or were strongly suspected of having, MRSA enteritis during the early postoperative period, were given oral VCM as four standard doses of 0.5g per day. The VCM concentrations in the blood, urine, and feces were then measured. No side effects were observed and the clinical efficacy of oral VCM in the 31 evaluable patients was excellent. There was a 100% clinical response rate and a 95.8% bacterial elimination rate in the feces. The clinical complete response (CR) rate to oral VCM differed significantly between patients in whom MRSA was detected only in the feces (100%) and those in whom MRSA was isolated from an additional source (57%) (P<0.01). Although VCM concentrations in the stools were extremely high, the levels in the blood and urine were very low. These results demonstrate that oral VCM should be the treatment of choice for postoperative MRSA enteritis due to its safety and efficacy.
Biochemical and Biophysical Research Communications | 1990
Masao Ichinose; Kazumasa Miki; Masae Tatematsu; Chie Furihata; Masashi Matsushima; Yoshikazu Ichihara; Masao Tanji; Toshiro Konishi; Masanobu Obara; Hideshi Inoue; Kiyoshi Kurokawa; Takayuki Takahashi; Takashi Kageyama; Kenji Takahashi
Direct adhesion of Helicobacter pylori to immobilized glycosphingolipids (GSLs) was compared to that of their corresponding oligosaccharide‐conjugated neoglycoconjugates in order to clarify the roles of the carbohydrate and lipid portions of GSLs in H. pylori adhesion. These bacteria were found to adhere to sulfatide, GM3, GalCer and LacCer, but not to ceramide, sphingomyelin, or polyacrylamides conjugated with β‐galactose, lactose, 3′‐sialyllactose or 3′‐sulfo‐β‐galactose. Furthermore, neoglycolipids or bovine serum albumin derivatives with corresponding oligosaccharides were unable to serve as the ligands. H. pylori adhesion to GalCer with α‐hydroxyl fatty acid was much stronger than GalCer with the non‐hydroxyl fatty acid. These results suggest that H. pylori recognize the conformation of GSL with α‐hydroxyl fatty acid on solid phase.